Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of a single treatment in a phase 1 and 2 study.
暂无分享,去创建一个
R Birngruber | E S Gragoudas | N. Bressler | Joan W. Miller | C. Pournaras | U. Schmidt-Erfurth | A. Strong | R. Birngruber | E. Gragoudas | C. Pournaras | A. Lane | J. W. Miller | L. Zografos | I. Barbazetto | M. Sickenberg | H. Laqua | U Schmidt-Erfurth | L Zografos | N M Bressler | J W Miller | H Laqua | G. Donati | M Sickenberg | I Barbazetto | B Piguet | C J Pournaras | G Donati | A M Lane | H van den Berg | U Manjuris | T Gray | M Fsadni | B. Piguet | A Strong | M. Fsadni | T. Gray | U. Manjuris | H. Berg | H. A. Strong | H. van den Berg | I. Barbazetto | Ulrike Manjuris
[1] Johannes R. Vingerling,et al. The prevalence of age-related maculopathy in the Rotterdam Study. , 1995, Ophthalmology.
[2] A. Jain,et al. Photosensitising potency of structural analogues of benzoporphyrin derivative (BPD) in a mouse tumour model. , 1991, British Journal of Cancer.
[3] Persistent and recurrent neovascularization after krypton laser photocoagulation for neovascular lesions of age-related macular degeneration. Macular Photocoagulation Study Group. , 1990, Archives of ophthalmology.
[4] B. Bengtsson,et al. DISC HAEMORRHAGE AND GLAUCOMA , 1981, Acta ophthalmologica.
[5] J Flammer,et al. Quantification of glaucomatous visual field defects with automated perimetry. , 1985, Investigative ophthalmology & visual science.
[6] R Birngruber,et al. Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of retreatments in a phase 1 and 2 study. , 1999, Archives of ophthalmology.
[7] A. Sommer,et al. Prevalence and significance of optic disc hemorrhage in a longitudinal study of glaucoma. , 1990, Archives of ophthalmology.
[8] C. Krakau,et al. REGRESSION ANALYSIS OF THE CENTRAL VISUAL FIELD IN CHRONIC GLAUCOMA CASES , 1982, Acta ophthalmologica.
[9] E. Gramer,et al. Quantifizierung und Progredienz des Gesichtsfeldschadens bei Glaukom ohne Hochdruck, Glaucoma simplex und Pigmentglaukom* , 1987 .
[10] A. Richter,et al. THE EFFECTS OF PLASMA LIPOPROTEINS ON in vitro TUMOR CELL KILLING and in vivo TUMOR PHOTOSENSITIZATION WITH BENZOPORPHYRIN DERIVATIVE , 1991, Photochemistry and photobiology.
[11] R. Klein,et al. Prevalence of age-related maculopathy. The Beaver Dam Eye Study. , 1992, Ophthalmology.
[12] J. Katz,et al. Analysis of progressive change in automated visual fields in glaucoma. , 1996, Investigative ophthalmology & visual science.
[13] R Birngruber,et al. Photodynamic therapy of experimental choroidal melanoma using lipoprotein-delivered benzoporphyrin. , 1994, Ophthalmology.
[14] D. Dolphin,et al. Biodistribution of tritiated benzoporphyrin derivative (3H-BPD-MA), a new potent photosensitizer, in normal and tumor-bearing mice. , 1990, Journal of photochemistry and photobiology. B, Biology.
[15] S. W. Siegner,et al. Optic disc hemorrhages and progression of glaucoma. , 1996, Ophthalmology.
[16] F. Ferris,et al. New visual acuity charts for clinical research. , 1982, American journal of ophthalmology.
[17] Erik L. Greve,et al. Some Possibilities of the Peritest Automatic and Semi-Automatic Perimeter , 1983 .
[18] U. Schmidt-Erfurth,et al. In vivo uptake of liposomal benzoporphyrin derivative and photothrombosis in experimental corneal neovascularization , 1995, Lasers in surgery and medicine.
[19] Joan W. Miller,et al. Liposomal benzoporphyrin derivative verteporfin photodynamic therapy. Selective treatment of choroidal neovascularization in monkeys. , 1996, Ophthalmology.
[20] S. Drance,et al. The rate of progression of scotomas in glaucoma. , 1986, American journal of ophthalmology.
[21] T J Flotte,et al. Photodynamic therapy of experimental choroidal neovascularization using lipoprotein-delivered benzoporphyrin. , 1995, Archives of ophthalmology.
[22] R. Hitchings,et al. The Nature of Visual Loss in Low Tension Glaucoma , 1985 .
[23] E. Gragoudas,et al. Photodynamic therapy of pigmented choroidal melanomas using a liposomal preparation of benzoporphyrin derivative. , 1996, Archives of ophthalmology.
[24] H A Quigley,et al. A comparison of Peritest automated perimetry and Goldmann perimetry. , 1985, Archives of ophthalmology.
[25] F L Ferris,et al. Senile macular degeneration: a case-control study. , 1983, American journal of epidemiology.
[26] J L Jay,et al. The rate of visual field loss in untreated primary open angle glaucoma. , 1993, The British journal of ophthalmology.
[27] David A. Dewey,et al. Corneal and retinal energy density with various laser beam delivery systems and contact lenses , 1991, Photonics West - Lasers and Applications in Science and Engineering.
[28] T J Dougherty,et al. Identification of singlet oxygen as the cytotoxic agent in photoinactivation of a murine tumor. , 1976, Cancer research.
[29] Joan W. Miller,et al. Intravenous infusion of liposomal benzoporphyrin derivative for photodynamic therapy of experimental choroidal neovascularization. , 1996, Archives of ophthalmology.
[30] C. Zhou,et al. Mechanisms of tumor necrosis induced by photodynamic therapy. , 1989, Journal of photochemistry and photobiology. B, Biology.
[31] B. Bengtsson,et al. The effect of perimetric experience in patients with glaucoma. , 1996, Archives of ophthalmology.
[32] E. Gragoudas,et al. Photodynamic therapy and digital angiography of experimental iris neovascularization using liposomal benzoporphyrin derivative. , 1997, Ophthalmology.
[33] A. Sommer,et al. Estimating progression of visual field loss in glaucoma. , 1997, Ophthalmology.
[34] L. Herndon,et al. Rate of progression in open-angle glaucoma estimated from cross-sectional prevalence of visual field damage. , 1997, American journal of ophthalmology.
[35] D. C. Wu,et al. Intraocular pressure and the rate of visual field loss in chronic open-angle glaucoma. , 1991, American journal of ophthalmology.
[36] R Birngruber,et al. Vascular targeting in photodynamic occlusion of subretinal vessels. , 1994, Ophthalmology.
[37] Joan W. Miller,et al. Effects of photodynamic therapy using verteporfin on experimental choroidal neovascularization and normal retina and choroid up to 7 weeks after treatment. , 1999, Investigative ophthalmology & visual science.
[38] B. Becker,et al. The onset and evolution of glaucomatous visual field defects. , 1982, Ophthalmology.
[39] E. Werner,et al. Effect of patient experience on the results of automated perimetry in clinically stable glaucoma patients. , 1988, Ophthalmology.
[40] S. Drance,et al. Disc hemorrhages in the glaucomas. , 1989, Survey of ophthalmology.
[41] S M Drance,et al. The mode of progression of visual field defects in glaucoma. , 1984, American journal of ophthalmology.
[42] F. Ferris,et al. Age-related macular degeneration and blindness due to neovascular maculopathy. , 1984, Archives of ophthalmology.